Inspire MD will be presenting at the Cowen & Company 34th Annual Health Care Conference at The Boston Marriott Copley Place at 9:20 a.m. EST on Wednesday, March 5, 2014.
InspireMD to Report Financial Results for Six Month Period Ended December 31, 2013 at 4:30 p.m. ET on Wednesday, February 26, 2014
InspireMD Ltd. is a high growth medical device company focusing on the development and commercialization of its proprietary stent platform technology: MGuard™.
InspireMD has created a unique, patent-pending mesh net technology that wraps a stent, providing embolic protection (preventing Major Adverse Cardiac Events (MACE) by filtering debris) and reducing vessel injury by spreading strut pressure. MGuard™ is delivered with no change to the current procedure and is well-accepted by physicians. MGuard™ has been implanted in thousands of patients, and in clinical trials it has shown a more than 50% reduction in MACE compared with traditional bare metal stents.